Atlas Trials

Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy

Clinical trial NCT05057104 · UNKNOWN

Trial details

NCT number
NCT05057104
Sponsor
Beijing 302 Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma Non-resectableConversion
Start date
2021-10-10
Primary completion
2024-12-31
Enrollment
320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.